Bishal Gyawali, Associate Professor at Queen’s University, shared a post by Chief Nerd, adding:
“This is a very positive step towards addressing regulatory capture.
Quoting Chief Nerd‘s post:
“MAKARY: ‘Today we are announcing we are removing pharma members from FDA advisory committees… We are going to be inviting pharma companies to send representatives to the advisory committees, but they can sit with the rest of the public and watch and pose questions’ “